Published in Am J Physiol on July 01, 1989
Specific features of glycogen metabolism in the liver. Biochem J (1998) 1.99
Energy metabolism in the liver. Compr Physiol (2014) 1.88
Hepatic energy state is regulated by glucagon receptor signaling in mice. J Clin Invest (2009) 1.39
Four grams of glucose. Am J Physiol Endocrinol Metab (2008) 1.37
Physiologic action of glucagon on liver glucose metabolism. Diabetes Obes Metab (2011) 1.32
The physiological regulation of glucose flux into muscle in vivo. J Exp Biol (2011) 1.15
Retracted Glucagon and lipid interactions in the regulation of hepatic AMPK signaling and expression of PPARalpha and FGF21 transcripts in vivo. Am J Physiol Endocrinol Metab (2010) 1.08
Regulation of net hepatic glycogenolysis and gluconeogenesis during exercise: impact of type 1 diabetes. J Clin Endocrinol Metab (2004) 1.08
Emerging role of AMP-activated protein kinase in endocrine control of metabolism in the liver. Mol Cell Endocrinol (2012) 0.97
Insulin and glucagon share the same mechanism of neuroprotection in diabetic rats: role of glutamate. Am J Physiol Regul Integr Comp Physiol (2011) 0.91
Minireview: Glucagon in stress and energy homeostasis. Endocrinology (2012) 0.90
Glucagon-to-insulin ratio is pivotal for splanchnic regulation of FGF-21 in humans. Mol Metab (2015) 0.89
Novel insight into glucagon receptor action: lessons from knockout and transgenic mouse models. Diabetes Obes Metab (2011) 0.86
Retracted Hepatic glucagon action is essential for exercise-induced reversal of mouse fatty liver. Diabetes (2011) 0.85
Mathematical modelling of local calcium and regulated exocytosis during inhibition and stimulation of glucagon secretion from pancreatic alpha-cells. J Physiol (2015) 0.82
Fractalkine (CX3CL1), a new factor protecting β-cells against TNFα. Mol Metab (2014) 0.81
The effects of endurance training and thiamine supplementation on anti-fatigue during exercise. J Exerc Nutrition Biochem (2013) 0.81
Effects of physical activity upon the liver. Eur J Appl Physiol (2014) 0.79
Effects of inducing physiological hyperglucagonemia on metabolic responses to exercise. Eur J Appl Physiol (2002) 0.78
Exercise and the Regulation of Hepatic Metabolism. Prog Mol Biol Transl Sci (2015) 0.77
Expression of gluconeogenic enzymes and 11β-hydroxysteroid dehydrogenase type 1 in liver of diabetic mice after acute exercise. Diabetes Metab Syndr Obes (2014) 0.76
β2-adrenergic regulation of stress hyperglycemia following hemorrhage in the obese Zucker rat. Physiol Rep (2014) 0.76
Muscle and liver glycogen utilization during prolonged lift and carry exercise: male and female responses. Physiol Rep (2017) 0.75
Regulation of glucose kinetics during exercise by the glucagon-like peptide-1 receptor. J Physiol (2012) 0.75
Dual roles for glucokinase in glucose homeostasis as determined by liver and pancreatic beta cell-specific gene knock-outs using Cre recombinase. J Biol Chem (1999) 10.14
Crystal structure of the anthrax lethal factor. Nature (2001) 3.75
Transcriptional repression by AML1 and LEF-1 is mediated by the TLE/Groucho corepressors. Proc Natl Acad Sci U S A (1998) 3.07
Biotechnology at low Reynolds numbers. Biophys J (1996) 2.72
Esthetic dentistry--a health service? J Dent Res (1993) 1.93
Importance of the design of an exercise protocol in the evaluation of patients with angina pectoris. Circulation (1971) 1.89
Phospholipase C and termination of G-protein-mediated signalling in vivo. Nat Cell Biol (2000) 1.88
Evidence that carotid bodies play an important role in glucoregulation in vivo. Diabetes (2000) 1.72
Acute takeoffs of the coronary arteries along the aortic wall and congenital coronary ostial valve-like ridges: association with sudden death. J Am Coll Cardiol (1984) 1.69
The role of fatty acids in mediating the effects of peripheral insulin on hepatic glucose production in the conscious dog. Diabetes (1997) 1.64
The role of insulin and glucagon in the regulation of basal glucose production in the postabsorptive dog. J Clin Invest (1976) 1.59
A comparison of the effects of selective increases in peripheral or portal insulin on hepatic glucose production in the conscious dog. Diabetes (1996) 1.53
Effect of glucagon on glucose production during insulin deficiency in the dog. J Clin Invest (1978) 1.52
Gluconeogenesis: methodological approaches in vivo. Fed Proc (1977) 1.47
Relationship between the plasma glucose level and glucose uptake in the conscious dog. Metabolism (1978) 1.44
Trapping and wiggling: elastohydrodynamics of driven microfilaments. Biophys J (1998) 1.44
Substrate-induced nuclear export and peripheral compartmentalization of hepatic glucokinase correlates with glycogen deposition. Int J Exp Diabetes Res (2001) 1.44
Treatment of angina pectoris by electrical stimulation of the carotid-sinus nerves. N Engl J Med (1969) 1.43
Effects of increased glucokinase gene copy number on glucose homeostasis and hepatic glucose metabolism. J Biol Chem (1997) 1.43
Role of brain in counterregulation of insulin-induced hypoglycemia in dogs. Diabetes (1989) 1.42
Thrombogenic factors and recurrent coronary events. Circulation (1999) 1.38
Circulatory effects of electrical stimulation of the carotid sinus nerves in man. Circulation (1969) 1.38
Laparoscopic adrenalectomy. A new standard of care. Ann Surg (1997) 1.37
Sustained effects of nitroglycerin ointment in patients with angina pectoris. Circulation (1974) 1.34
Comparison of the time courses of insulin and the portal signal on hepatic glucose and glycogen metabolism in the conscious dog. J Clin Invest (1996) 1.33
Physiologic action of glucagon on liver glucose metabolism. Diabetes Obes Metab (2011) 1.32
Medical management of patients with angina pectoris. Prog Cardiovasc Dis (1972) 1.30
Clinical and circulatory effects of isosorbide dinitrate. Comparison with nitroglycerin. Circulation (1971) 1.29
Twirling and whirling: viscous dynamics of rotating elastic filaments. Phys Rev Lett (2000) 1.29
Effects of a reduction in environmental temperature on the circulatory response to exercise in man. Implications concerning angina pectoris. N Engl J Med (1969) 1.29
Hyperglycemia per se (insulin and glucagon withdrawn) can inhibit hepatic glucose production in man. J Clin Endocrinol Metab (1979) 1.28
Counterregulation during hypoglycemia is directed by widespread brain regions. Diabetes (1993) 1.28
Absorption and disposition of a glucose load in the conscious dog. Am J Physiol (1982) 1.27
Intraoperative coronary collateral function in patients with coronary occlusive disease. Nitroglycerin responsiveness and angiographic correlations. Circulation (1974) 1.27
Glucose disposal during insulinopenia in somatostatin-treated dogs. The roles of glucose and glucagon. J Clin Invest (1978) 1.26
Impairment of cardiac function in patients with pectus excavatum, with improvement after operative correction. N Engl J Med (1972) 1.25
Beneficial effects of vagal stimulation and bradycardia during experimental acute myocardial ischemia. Circulation (1974) 1.24
2010 ACVIM small animal consensus statement on leptospirosis: diagnosis, epidemiology, treatment, and prevention. J Vet Intern Med (2010) 1.23
Intraportal glucose delivery alters the relationship between net hepatic glucose uptake and the insulin concentration. J Clin Invest (1991) 1.22
Small amounts of fructose markedly augment net hepatic glucose uptake in the conscious dog. Diabetes (1998) 1.19
Small increases in insulin inhibit hepatic glucose production solely caused by an effect on glycogen metabolism. Diabetes (2001) 1.19
Evidence for an important role of glucagon in the regulation of hepatic glucose production in normal man. J Clin Invest (1977) 1.19
Potential role of QT interval prolongation in sudden infant death syndrome. Circulation (1976) 1.19
Basal hepatic glucose production is regulated by the portal vein insulin concentration. Diabetes (1998) 1.18
Reduction of ischemic injury by nitroglycerin during acute myocardial infarction. N Engl J Med (1975) 1.17
Hypoglycemia in IDDM. Diabetes (1989) 1.15
Sources of carbon for hepatic glycogen synthesis in the conscious dog. J Clin Invest (1991) 1.15
Role of insulin in the regulation of leucine kinetics in the conscious dog. J Clin Invest (1982) 1.15
Effect of glucose, independent of changes in insulin and glucagon secretion, on alanine metabolism in the conscious dog. J Clin Invest (1980) 1.14
Impairment of autonomically mediated heart rate control in patients with cardiac dysfunction. Circ Res (1975) 1.13
Selection for spiral waves in the social amoebae Dictyostelium. Proc Natl Acad Sci U S A (1997) 1.13
Importance of the route of intravenous glucose delivery to hepatic glucose balance in the conscious dog. J Clin Invest (1987) 1.13
Effect of arginine on glucose turnover and plasma free fatty acids in normal dogs. Diabetes (1973) 1.12
The roles of insulin, glucagon, and free fatty acids in the regulation of ketogenesis in dogs. Diabetes (1977) 1.10
Differential time course of glucagon's effect on glycogenolysis and gluconeogenesis in the conscious dog. Diabetes (1981) 1.09
The effect of somatostatin on glucose uptake and production by rat tissues in vitro. Diabetes (1977) 1.08
Chiral self-propulsion of growing bacterial macrofibers on a solid surface. Phys Rev Lett (2000) 1.08
Groucho augments the repression of multiple Even skipped target genes in establishing parasegment boundaries. Development (2001) 1.08
Blood fibrinolytic activity in man. Diurnal variation and the response to varying intensities of exercise. Circ Res (1970) 1.08
Hepatic fuel metabolism during muscular work: role and regulation. Am J Physiol (1991) 1.07
Acute fructose administration decreases the glycemic response to an oral glucose tolerance test in normal adults. J Clin Endocrinol Metab (2000) 1.06
Effect of interaction between insulin and glucagon on glucose turnover and FFA concentration in normal and depancreatized dogs. Metabolism (1974) 1.06
Impact of chronic stress hormone infusion on hepatic carbohydrate metabolism in the conscious dog. Am J Physiol (1993) 1.06
Control of hepatic glucose output by glucagon and insulin in the intact dog. Biochem Soc Symp (1978) 1.05
Study of need for esthetics in dentistry. J Prosthet Dent (1969) 1.05
Compartmental modeling of glucagon kinetics in the conscious dog. Metabolism (1995) 1.05
The relationship of mucosal bacteria to duodenal histopathology, cytokine mRNA, and clinical disease activity in cats with inflammatory bowel disease. Vet Microbiol (2007) 1.04
Glucokinase gene locus transgenic mice are resistant to the development of obesity-induced type 2 diabetes. Diabetes (2001) 1.04
Interaction between insulin and glucose-delivery route in regulation of net hepatic glucose uptake in conscious dogs. Diabetes (1990) 1.03
Hemodynamic abnormalities in response to mild and intense upright exercise following operative correction of an atrial septal defect or tetralogy of Fallot. Circulation (1973) 1.02
Insulin as a mediator of hepatic glucose uptake in the conscious dog. Am J Physiol (1982) 1.02
Reduction in severity and extent of myocardial infarction when nitroglycerin and methoxamine are administered during coronary occlusion. Circulation (1974) 1.01
Acute fructose administration improves oral glucose tolerance in adults with type 2 diabetes. Diabetes Care (2001) 1.01
A negative arterial-portal venous glucose gradient decreases skeletal muscle glucose uptake. Am J Physiol (1998) 1.01
Autoregulation of hepatic glucose production. Eur J Endocrinol (1998) 1.00
Insulin-independent effects of GLP-1 on canine liver glucose metabolism: duration of infusion and involvement of hepatoportal region. Am J Physiol Endocrinol Metab (2004) 1.00
Labyrinthine pattern formation in magnetic fluids. Science (1993) 0.99
Evidence that the brain of the conscious dog is insulin sensitive. J Clin Invest (1995) 0.99
Regulation of net hepatic glucose uptake in vivo. Annu Rev Physiol (1992) 0.99
Role of carotid bodies in control of the neuroendocrine response to exercise. Am J Physiol Endocrinol Metab (2001) 0.99
Arginine infusion in dogs. Model for the roles of insulin and glucagon in regulating glucose turnover and free fatty acid levels. Diabetes (1974) 0.99
Importance of hypoglycemia-induced glucose production during isolated glucagon deficiency. Am J Physiol (1979) 0.98
Comparison of the peak inotropic effects of a catecholamine and a digitalis glycoside in the intact canine heart. Circulation (1970) 0.97
Bleaching vital teeth: state of the art. Quintessence Int (1989) 0.97
Interaction of exercise and insulin action in humans. Am J Physiol (1991) 0.97
Disposition of a mixed meal by the conscious dog. Am J Physiol (1994) 0.97
Exercise-induced fall in insulin and hepatic carbohydrate metabolism during muscular work. Am J Physiol (1989) 0.96
Effect of hyperglycemia independent of changes in insulin or glucagon on lipolysis in the conscious dog. Metabolism (1980) 0.96
Intraportal glucose delivery enhances the effects of hepatic glucose load on net hepatic glucose uptake in vivo. J Clin Invest (1991) 0.95
Mechanisms of hormonal regulation of liver metabolism. Adv Cyclic Nucleotide Res (1981) 0.95
Effect of hyperglucagonemia on hepatic glycogenolysis and gluconeogenesis after a prolonged fast. Am J Physiol (1990) 0.95
Influence of sulfinpyrazone and naproxen on infarct size in the dog. Am J Cardiol (1981) 0.95
Ketone body turnover and net hepatic ketone production in fasted and diabetic dogs. Am J Physiol (1978) 0.95
Hepatic denervation does not significantly change the response of the liver to glucagon in conscious dogs. Am J Physiol (1995) 0.94
Differential effect of amino acid infusion route on net hepatic glucose uptake in the dog. Am J Physiol (1999) 0.94